A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
ACTIVE_NOT_RECRUITING
Status
Conditions
- Systemic Lupus Erythematosus
Interventions
- DRUG: Afimetoran
- OTHER: Placebo
Sponsor
Bristol-Myers Squibb